Filing Details

Accession Number:
0001708138-21-000064
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-20 16:02:05
Reporting Period:
2021-08-18
Accepted Time:
2021-08-20 16:02:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218629 S Leonard Schleifer 777 Old Saw Mill River Road
Tarrytown NY 10591
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-18 200,000 $650.03 304,746 No 4 S Direct
Common Stock Disposition 2021-08-19 10,000 $660.03 21,178 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 200,000 Indirect 2021 GRAT
Common Stock 5,874 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 200,000 shares of Company stock on August 18, 2021 at prices ranging from $650.00 to $650.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2021 at each separate price.
  3. Represents volume-weighted average price of sales of 10,000 shares of Company stock on August 19, 2021 at prices ranging from $660.00 to $660.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 19, 2021 at each separate price.
  4. These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust.